Company: FWDI
Filing Date: 2025-12-11
Form Type: 10-K
Source: 0001683168-25-009068
Chunk: 749

Company: Forward Industries, Inc.
Filing Date: 2025-12-11
Form: 10-K
Item: Item 5
Chunk 749
---
Dividends through September 30, 2025, were capitalized by increasing the stated value of each share of the Series B.

On May 23, 2025, the Company
entered into a Preferred Stock Purchase Agreement (the “PS Agreement”) and related Registration Rights Agreement (the “Series
B Registration Rights Agreement”) with two accredited investors (the “Series B Investors”) whereby the Company granted
the investors an aggregate of 1,000,000 shares of the Series B and warrants to purchase an additional 111,111 shares of common stock (the
“Series B Warrants”) in exchange for $1,000,000. The PS Agreement contained restrictions on the Company’s ability to
incur debt, issue additional preferred shares, enter into a change of control transaction or make restricted payments without prior written
consent of the investors. These restrictions were terminated pursuant to the Waiver and Leak-out Agreement described below. The Company
paid third-party fees of $66,500 associated with this agreement, of which $29,000 related to the preferred stock portion of the agreement
and has been deducted from the proceeds and recorded as a reduction of additional paid-in capital, and $37,500 related to the warrants
and has been recorded as a component of general and administrative expenses on the consolidated financial statements at September 30,
2025.

In September 2025, in connection
with the Securities Purchase Agreement, the Company entered into a waiver and leak-out agreement (the “Waiver and Leak-out Agreement”)
with the Series B Investors, pursuant to which the Series B Investors agreed to (i) the termination, waiver or amendment of all covenants
and provisions to forgo all of their rights under the Series B Warrants, the PS Agreement and the Series B Registration Rights Agreement,
including a general release from any liability for prior non-performance, and (ii) provide conversion notices and such other documentation
reasonably requested by the Company in order to complete the conversion of all of the Series B into shares of common stock. On September
10, 2025, all outstanding shares of the Series B were converted into 228,765 shares of the Company’s common stock. Following the
conversion, no shares of Series B remain outstanding.

In connection with the Waiver
and Leak-out Agreement, the Company granted the Series B Investors the right to purchase up to $33,000,000 worth of shares of Common Stock
at a purchase price of $18.50 per share; and